A detailed history of Wealth Alliance Advisory Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealth Alliance Advisory Group, LLC holds 17,640 shares of BMY stock, worth $1.03 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
17,640
Previous 6,809 159.07%
Holding current value
$1.03 Million
Previous $282,000 223.4%
% of portfolio
0.21%
Previous 0.07%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$39.66 - $51.75 $429,557 - $560,504
10,831 Added 159.07%
17,640 $912,000
Q2 2024

Jul 30, 2024

SELL
$40.25 - $52.99 $19,521 - $25,700
-485 Reduced 6.65%
6,809 $282,000
Q1 2024

Apr 15, 2024

SELL
$47.98 - $54.4 $1,055 - $1,196
-22 Reduced 0.3%
7,294 $395,000
Q4 2023

Jan 10, 2024

SELL
$48.48 - $57.85 $13,671 - $16,313
-282 Reduced 3.71%
7,316 $375,000
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $38,207 - $42,721
660 Added 9.51%
7,598 $440,000
Q2 2023

Jul 13, 2023

SELL
$63.71 - $70.74 $16,500 - $18,321
-259 Reduced 3.6%
6,938 $443,000
Q1 2023

May 02, 2023

BUY
$65.71 - $74.53 $6,570 - $7,453
100 Added 1.41%
7,197 $498,000
Q4 2022

Jan 17, 2023

SELL
$68.48 - $81.09 $19,859 - $23,516
-290 Reduced 3.93%
7,097 $0
Q3 2022

Oct 12, 2022

SELL
$0.13 - $76.84 $9 - $5,609
-73 Reduced 0.98%
7,387 $525,000
Q2 2022

Jul 08, 2022

SELL
$72.62 - $79.98 $3,413 - $3,759
-47 Reduced 0.63%
7,460 $574,000
Q1 2022

Apr 18, 2022

SELL
$61.48 - $73.72 $246,165 - $295,174
-4,004 Reduced 34.78%
7,507 $548,000
Q4 2021

Jan 13, 2022

SELL
$53.63 - $62.52 $116,055 - $135,293
-2,164 Reduced 15.82%
11,511 $718,000
Q3 2021

Oct 08, 2021

SELL
$59.17 - $69.31 $25,147 - $29,456
-425 Reduced 3.01%
13,675 $809,000
Q2 2021

Jul 13, 2021

BUY
$61.91 - $67.42 $309 - $337
5 Added 0.04%
14,100 $942,000
Q1 2021

Apr 28, 2021

BUY
$59.34 - $66.74 $90,730 - $102,045
1,529 Added 12.17%
14,095 $890,000
Q4 2020

Jan 25, 2021

BUY
$57.74 - $65.43 $5,774 - $6,543
100 Added 0.8%
12,566 $779,000
Q3 2020

Oct 08, 2020

SELL
$57.43 - $63.64 $44,106 - $48,875
-768 Reduced 5.8%
12,466 $752,000
Q2 2020

Jul 08, 2020

SELL
$54.82 - $64.09 $8,003 - $9,357
-146 Reduced 1.09%
13,234 $778,000
Q1 2020

Apr 15, 2020

BUY
$46.4 - $67.43 $6,449 - $9,372
139 Added 1.05%
13,380 $746,000
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $89,562 - $116,825
1,820 Added 15.94%
13,241 $850,000
Q3 2019

Nov 01, 2019

BUY
$42.77 - $50.71 $4,105 - $4,868
96 Added 0.85%
11,421 $589,000
Q2 2018

Jul 20, 2018

SELL
$50.53 - $62.98 $4,497 - $5,605
-89 Reduced 0.78%
11,325 $627,000
Q1 2018

Jun 01, 2018

BUY
$59.92 - $68.98 $107,856 - $124,164
1,800 Added 18.72%
11,414 $722,000
Q4 2017

Apr 11, 2018

BUY
$59.94 - $65.35 $576,263 - $628,274
9,614
9,614 $589,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wealth Alliance Advisory Group, LLC Portfolio

Follow Wealth Alliance Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance Advisory Group, LLC with notifications on news.